Even Healthcare
Even Healthcare combines hospital care, care coordination and digital follow-up for patients in India.
$50MSeries B
ParticipantAW
Alpha Wave
Activity from announced rounds
Activity in this selectionOct 19, 2026 · Jul 22, 2026
Alpha Wave is the investment-manager name used in the covered financings and connected to Alpha Wave Global’s official press and investment records.
Recorded funding activity
The recorded activity includes a lead role in Moonwalk Biosciences’ Series B for medicines targeting fat-tissue pathways in obesity and cardiometabolic disease. Other announcements concern AdvanCell’s targeted alpha radiopharmaceuticals for cancer and Ultrahuman’s wearable ring and health-testing products. These events describe the activity captured here rather than the manager’s complete allocation.
- Rounds participated in
- 3
- Confirmed lead rounds
- 1 All roles disclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $190M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionMoonwalk Biosciences
Moonwalk Biosciences is developing adipose-targeted siRNA medicines for obesity and cardiometabolic disease. Its lead programs are designed to alter fat-tissue pathways while limiting effects on other tissues, with the lead obesity candidate in IND-enabling development ahead of planned human testing in 2027.
$70MSeries B
LeadUltrahuman
Ultrahuman combines a wearable ring with app-based health insights and complementary testing.
$70MFunding round
Participant